These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2165009)

  • 81. Challenging assumptions about Alzheimer's disease: mild cognitive impairment and the cholinergic hypothesis.
    Morris JC
    Ann Neurol; 2002 Feb; 51(2):143-4. PubMed ID: 11835369
    [No Abstract]   [Full Text] [Related]  

  • 82. Alzheimer's disease and neural transplantation as prospective cell therapy.
    Oliveira AA; Hodges HM
    Curr Alzheimer Res; 2005 Jan; 2(1):79-95. PubMed ID: 15977991
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cells engineered to produce acetylcholine: therapeutic potential for Alzheimer's disease.
    Fisher LJ; Raymon HK; Gage FH
    Ann N Y Acad Sci; 1993 Sep; 695():278-84. PubMed ID: 8239296
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Loss of glutaminase-positive cortical neurons in Alzheimer's disease.
    Akiyama H; McGeer PL; Itagaki S; McGeer EG; Kaneko T
    Neurochem Res; 1989 Apr; 14(4):353-8. PubMed ID: 2761669
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neurochemical studies of Alzheimer's disease.
    Palmer AM
    Neurodegeneration; 1996 Dec; 5(4):381-91. PubMed ID: 9117551
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cholinergic controversies.
    Ridley RM; Baker HF; Fine A
    Trends Neurosci; 1991 Nov; 14(11):482-3; author reply 485-6. PubMed ID: 1726762
    [No Abstract]   [Full Text] [Related]  

  • 87. Excitatory amino acids and Alzheimer's disease: idle thoughts on an exciting subject.
    McGeer EG
    Neurobiol Aging; 1989; 10(5):614-6; discussion 618-20. PubMed ID: 2554171
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pyramidal neurone modulation: a therapeutic target for Alzheimer's disease.
    Francis PT
    Neurodegeneration; 1996 Dec; 5(4):461-5. PubMed ID: 9117563
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cholinergic neuromodulation and Alzheimer's disease: from single cells to network simulations.
    Menschik ED; Finkel LH
    Prog Brain Res; 1999; 121():19-45. PubMed ID: 10551018
    [No Abstract]   [Full Text] [Related]  

  • 90. Extra-pyramidal symptoms in Alzheimer's disease: a hypothesis.
    Horn D; Ruppin E
    Med Hypotheses; 1992 Dec; 39(4):316-8. PubMed ID: 1494318
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Human brain cholinergic pathways.
    Mesulam MM
    Prog Brain Res; 1990; 84():231-41. PubMed ID: 2267300
    [No Abstract]   [Full Text] [Related]  

  • 92. Pathogenesis of Alzheimer's disease--beyond the cholinergic hypothesis: discussion paper.
    Harrison PJ
    J R Soc Med; 1986 Jun; 79(6):347-52. PubMed ID: 2873250
    [No Abstract]   [Full Text] [Related]  

  • 93. The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease.
    Cacabelos R; Takeda M; Winblad B
    Int J Geriatr Psychiatry; 1999 Jan; 14(1):3-47. PubMed ID: 10029935
    [No Abstract]   [Full Text] [Related]  

  • 94. Neurobiological bases for Alzheimer's disease.
    Maier-Lorentz MM
    J Neurosci Nurs; 2000 Apr; 32(2):117-25. PubMed ID: 10826298
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate.
    Deutsch SI; Morihisa JM
    Clin Neuropharmacol; 1988 Feb; 11(1):18-35. PubMed ID: 3280127
    [No Abstract]   [Full Text] [Related]  

  • 96. Transmitter deficits in Alzheimer's disease.
    Hardy J; Adolfsson R; Alafuzoff I; Bucht G; Marcusson J; Nyberg P; Perdahl E; Wester P; Winblad B
    Neurochem Int; 1985; 7(4):545-63. PubMed ID: 20492959
    [TBL] [Abstract][Full Text] [Related]  

  • 97. "Autocannibalism" of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease-A hypothesis.
    Wurtman RJ; Blusztajn JK; Maire JC
    Neurochem Int; 1985; 7(2):369-72. PubMed ID: 20492936
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Neuron recognition by parallel Potts segmentation.
    Peng S; Urbanc B; Cruz L; Hyman BT; Stanley HE
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):3847-52. PubMed ID: 12651959
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.
    Danysz W; Parsons CG
    Br J Pharmacol; 2012 Sep; 167(2):324-52. PubMed ID: 22646481
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?
    Esposito Z; Belli L; Toniolo S; Sancesario G; Bianconi C; Martorana A
    CNS Neurosci Ther; 2013 Aug; 19(8):549-55. PubMed ID: 23593992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.